My HPRA: Register

CANDESARTAN HYDROCHLOROTHIAZIDE ACTAVIS

8/12.5 Milligram Tablets

Actavis Group PTC ehfPA1380/126/001

Main Information

Trade NameCANDESARTAN HYDROCHLOROTHIAZIDE ACTAVIS
Active SubstancesCANDESARTAN CILEXETIL
HYDROCHLOROTHIAZIDE
Strength8/12.5 Milligram
Dosage FormTablets
Licence HolderActavis Group PTC ehf
Licence NumberPA1380/126/001

Group Information

ATC CodeC09DA06 Angiotensin II antagonists and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued20/04/2012
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing StatusNot Marketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListCandesartan/Hydrochlorothiazide 8mg/12.5mg Tablets
Interchangeable List CodeIC0029-058-002
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.